Testimony of Roger Landry, Former
Maine State Representative, and
Co-Chair of Maine’s Task Force on Veterans’ Health Services,
Before the House Committee in Veterans Affairs Subcommittee on Health
August 22, 2005
Congressman Michaud and distinguished members of the Committee. My name
is Roger Landry; I am retired from the U.S. Air Force having served
honorably for 22 years. I am also 100% disabled with the Veterans
Administration with throat cancer derived from exposure to Agent Orange
in Southeast Asia during the period of 1967 to 1968. I have spent the
last 12 years working extensively with various veterans organizations in
an effort to better the lives of our Veterans. Most recently, I served
as a State Representative in the 121st Maine State Legislature for
District 10 which is Sanford, Maine. During my short tenure in the State
House I was able to bring numerous veterans’ issues to the attention of
our State government the most significant of which is veterans’ health
care as provided by the Veterans’ Administration.
Let me begin by saying that I truly believe that the VA health care
system in Maine and its staff are doing their level best to provide
adequate health care to our veterans. However, recent developments in
the economics, demographics, and ever changing geography of our Maine
veterans’ world have caused us all to re-examine that level of adequacy
in our VA health care system. Namely, the aging of the American Veteran,
the increased enrollment of uninsured into the VA, the increasing cost
of providing healthcare, including prescription drugs, and a federal
budget environment in which – without changes to the VA’s funding
mechanism – it appears increasingly likely that VA funding will not keep
pace with costs faced by the VA, suggests that a ‘Perfect Storm’
scenario may be brewing for our nation’s veterans just at the time when
they need the system most.
Further, as has others have mentioned in their testimony, the CARES
study found significant access gaps in Maine. The study came up with
recommendations to close some – but not all – of the access gaps faced
by Maine veterans, but, as you have heard, the CARES recommendations
will not be implemented for a number of years.
In addition, Senator Collins of Maine has a bill in to allocate funding
to provide better transportation for veterans to existing VA health care
facilities. While this bill, if successful, will diminish the problem
somewhat, it can by no means eliminate the problem.
For these reasons, it is critical that here in Maine, a state with the
one of the nation’s highest percentage of veterans (in the 2000 Census,
veterans constituted 15.9% of Maine’s population age 18 and over, while
the average among the 50 states and District of Columbia was 13.5%) and
with a population older than the rest of the country, we provide the
leadership to a more efficient, more accessible, and more compassionate
healthcare system for our national veterans.
In 2003, as part of the Dirigo Health Reform Act, Governor Baldacci and
the Maine Legislature created a Task Force to review and assess the
needs of the State's veterans for health care services and the
availability, accessibility and quality of public and private health
care services for veterans, and to make recommendations based on its
review and assessment.
The Task Force, which I co-chaired, met almost monthly from December
2003 to January 2005, when it issued a report to the Legislature. This
report, which was later forwarded to the Maine Congressional and
Senatorial delegation, contained proposals that we are planning to
provide to Secretary Nicholson soon. One proposal that we submitted was
the decision of Governor Baldacci to join all four members of Maine’s
Congressional delegation in endorsing a Congressional measure to obtain
mandatory funding for veterans health care as soon as possible, and that
he encourage the National Governors’ Association to endorse the measure.
My testimony today alludes to that aspect of the overall problem with
veterans’ health care, affordability and accessibility being the key
factors.
Because of the high cost of prescription drugs faced by many veterans,
the Task Force also proposed that the VA conduct a pilot program in
Maine to allow private physicians to write prescriptions that can be
filled through the VA formulary, for a limited number of veterans living
beyond a specified distance from a VA facility.
I will spend the remainder of my testimony giving the details of this
proposal and explaining why it is in the best interest of both the VA
and Maine’s and the nation’s veterans.
As we are all aware, because of a law allowing the VA to negotiate
discounted prices on prescription drugs on behalf of the VA, the
Department of Defense, the Public Health Service and the Coast Guard,
the VA is able to offer some of the lowest prices on prescription drugs
in the country. In order to access the drug benefit, veterans must
enroll with the VA and receive prescriptions from a VA physician.
Prescriptions that veterans receive from a private physician may not be
filled through the VA.
The VA has stated that many veterans are enrolling in the VA system
seeking only pharmacy benefits. In other words, it appears that many
veterans who might not otherwise have enrolled with the VA – veterans
who have sufficient means to see a private physician but not necessarily
to pay for prescription drugs – enroll to access the drug benefit.
There is considerable anecdotal evidence that many veterans receive care
both from private community physicians as well as from the VA. This is
especially true when veterans wish to avail themselves of the
considerable discounts that the VA is able to offer on prescription
drugs. To access this money saving benefit, they must see a VA provider
at least yearly, either in Togus or one of the outlying clinics. This
often involves a wait for an appointment, travel to a distant clinic,
and duplicative health care with several primary care clinicians
managing health care for the same patient. If the community physician
wants to change a prescribed drug, the veteran must see a VA physician
for approval. This often leads to duplicate lab tests, X-rays, and
screening exams, increasing the cost to our health system, fragmenting
care, delaying the veteran’s obtaining medications, and inconveniencing
the veteran, the VA, and the community physician.
Although many veterans put up with this cumbersome, costly, and
fragmented system, a system that allows veterans to obtain primary care
health services from their private physicians and prescription drugs
through the VA pharmacy is what many veterans desire.
Accordingly, a number of bills have been introduced in Congress to allow
the VA to fill prescriptions written by community physicians. The VA has
opposed these bills for a number of reasons. Two primary reasons are:
• Cost. As you are aware, unlike the federal Medicare program, whose
funding is mandatory and thus automatically additional increases when
enrollment increases, the VA receives a fixed budget that is determined
each year through the appropriations process. The VA has pointed out
that if Congress expanded the drug benefit without providing additional
funds to pay for the expansion, the expansion “would tend to erode the
comprehensive medical care benefits that veteran users of the VA health
care system now enjoy” by crowding out spending on core services.
• VA’s Drug Benefit is Part of VA’s Coordinated System of Care. The VA
has stated that it “strongly believes that drug therapy must be
coordinated, monitored, and managed by a single primary care provider.
VA has maintained control over the cost of its prescription benefit by
using sophisticated formulary management techniques and by assuring that
prescriptions written by VA staff are consistent with the formulary
management process.”
Advocates for these bills have argued that the VA would realize savings
from the passage of these bills as a result of a reduction in
duplication of services, and that these savings would outweigh any
additional costs to the VA. A December 2000 report by the VA Inspector
General (IG) estimated the cost of the re-examinations at $1.3 billion
in 2001. However, the VA believes that there were significant flaws in
the IG’s methodology and has indicated that the IG is continuing to
examine its methodology. The VA’s position is that increase in
enrollment would likely outweigh savings from reduction in duplication
of services.
Pilot Program Proposal. With these concerns in mind, the Task Force
proposes that the VA conduct a three-year state-wide pilot program in
Maine to test the feasibility of allowing a limited number of eligible
veterans to obtain prescription drugs from the VA through their
community physician. The pilot could include an evaluation to help
assess whether the pilot might be worthwhile in other rural states.
Under the terms of the proposed pilot, veterans who live at distances
greater than the CARES guidelines (i.e., more than 60 miles in a rural
area and 30 miles in an urban area) would be eligible to receive VA
pharmacy benefits based on an initial visit with a VA physician. After
the initial visit, a community physician would manage on-going care,
including prescriptions. The veteran would enroll with the VA system and
be required to see a VA physician every three years, rather than
annually. Veterans enrolled in this program would pay a higher co-pay –
to be established by the VA – and in return have the benefits of
maintaining a relationship with their community physician, reducing
unnecessary travel and duplication of services.
Specific elements of the proposal:
• Increased co-payments to ensure cost neutrality to the VA, with all
participants subject to co-payments, regardless of priority group. The
Task Force proposes that the VA establish a co-payment system that would
enable the VA to fully recapture any additional cost to the VA of
increased enrollment and prescription drug expenditures. This could
include varying co-payments for specific drugs. The VA could adjust the
co-payment schedule annually to account for differences between
projected and actual expenditures each year.
• An enrollment cap set by the VA to limit the size of the pilot, and a
program evaluation to assist the VA in monitoring impact of the pilot.
The VA could work with a local organization, such as from the University
of Maine system or the University of New England, to design the pilot.
This could include establishing an enrollment cap to balance the need to
keep the pilot to a limited size while allowing statistically
significant analysis, as well as to ensure enrollment of individuals
from different parts of the state. The evaluation could answer such
questions as:
- What is the magnitude of savings to the VA from reduction in
duplication of services? Does the pilot free up VA resources for
veterans needing core services?
- What is the demand for the program?
- How do per-enrollee pharmacy expenditures in the pilot compare to
per-enrollee outpatient pharmacy expenditures in the VA system?
- What would the cost to the VA have been in the absence of the
increased cost-sharing proposed by the pilot? Would those costs have
been outweighed by savings from reduction in duplication of services?
- How does enrollment break out between veterans who had already been
driving to VA facilities for prescription drugs and those who are
enrolling with the VA for the first time? Is there a reduction in the
number of veterans who begin using VA services solely because they want
access to the drug benefit?
• Requiring Participating Veterans to Use a Single Primary Care
Physician. The enrollee must agree to use one primary-care physician,
who would coordinate, monitor, and manage the veteran’s care for the
duration of their participation on the pilot. Any specialist wishing to
write a prescription for the participating veteran would need to consult
with the primary care physician before writing a prescription. The
purpose of this provision would be to maximize the potential for the
effective medication management to ensure cost effectiveness and safe,
quality care.
• The VA would determine which priority groups would be included in the
pilot. The VA might choose to include priority group 8 in the pilot,
since there would be no additional cost to the VA.
• Only veterans who live at distances greater than the CARES guidelines
(i.e., more than 60 miles in a rural area and 30 miles in an urban area)
would be eligible to participate.
Potential Benefits of the Pilot Program
• To Everyone:
– Would free up essential Togus resources as Maine veterans return home
from Iraq and Afghanistan and other areas of deployment.
• To Veterans:
– Continuity of care; ability to maintain relationship with local
doctor; easier for veterans to access the lower-priced prescription
drugs to which they are entitled, with less travel and delay.
• To Togus and Togus Physicians:
– Eliminates duplication; increases efficiency; allows Togus to target
veterans with specific service-related health issues; reduces waiting
lists. This would be good public relations for Togus and could help
retention of Togus doctors.
– Could increase funding for Togus by enrolling veterans who would not
otherwise enroll.
• To private physicians:
– Patients who are veterans can access lower-priced prescription drugs
without redundancy of effort.
– Less red-tape in providing prescriptions to patients who are veterans.
– Continuity of care.
• To the VA, Congress, and the nation’s veterans:
– There has been interest nationwide in somehow expanding the VA’s
pharmacy benefit. Maine’s serving as a pilot, with a strong evaluation
component, could answer essential questions regarding the costs and
benefits of such a program. The pilot and study could be used as a basis
for estimating the impact of such a program nationwide, or at least in
other rural states.
• Other benefits:
– Fits VA “ CARES Program” initiative to provide reasonable access to
care
– Fosters cooperation between State and Federal government.
In conclusion let me state for the record that we feel our proposals are
solid, feasible and completely based on factual research. The Task Force
-- which was comprised of members from all parts of Maine society to
include veterans, doctors, business people, social workers and
psychologists -- worked very hard to produce the most viable report of
this type. Our ultimate goal is to have Secretary Nicholson review our
proposals and give them due consideration. The opportunity to testify
before this Committee gives us one more step closer to that goal. On
behalf of the Task Force and especially the deserving veterans of Maine,
I thank Congressman Michaud for his incredibly strong support in our
efforts, and I thank the Committee for its time. I will now make myself
available for any questions or comments the Committee may have.
|